Evidence map›Paper›PMID 41112685›Full record

ArticleFrontiers in research metrics and analytics2025

Growth in representation of Saudi scientists among Stanford's top 2 percent most-cited (2019-2023).

Luluah Altukhaifi, Nouf Alturaiki, Khaled Al-Hadyan

Abstract read
In one paragraph

Article in Frontiers in research metrics and analytics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Luluah AltukhaifiResearch Affairs Department, Research and Innovation, King Faisal Specialist Hospital and Research Centre (KFSHRC), Riyadh, Saudi Arabia.
Nouf AlturaikiResearch Affairs Department, Research and Innovation, King Faisal Specialist Hospital and Research Centre (KFSHRC), Riyadh, Saudi Arabia.
Khaled Al-HadyanRadiation Biology Section, Biomedical Physics Department, Research and Innovation, King Faisal Specialist Hospital and Research Centre (KFSHRC), Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Global citation-based databases, such as Stanford University's Top 2% Scientists (SUD2%) database, offer powerful tools for tracking high-impact researchers. Despite Saudi Arabia's growing investment in scientific research, a longitudinal analysis of its presence in these elite citation rankings has been lacking. This study provides the first 5-year analysis (2019-2023) of Saudi-affiliated scientists listed in the SUD2% (single-year category), evaluating their growth in numbers, performance indicators, disciplinary distribution, and gender representation. Data were extracted from Elsevier's Mendeley-hosted SUD2% dataset. The key bibliometric metrics under analysis included the average composite citation score (C-score), citation rank, total citations, and h-index. A one-way repeated measures ANOVA on ranks was used to assess statistical differences between Saudi-affiliated and global scientists. Gender classification was performed using NamSor, based on validated confidence thresholds. The number of Saudi-affiliated scientists in the SUD2% nearly tripled from 556 in 2019 to 1,684 in 2023. Significant gains were also observed in average C-scores (

Indexed as

bibliometric analysiscitation metricsh-indexSaudi ArabiaStanford's top 2 percent most-cited scientists

Identifiers

PMID41112685
PMCPMC12528147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.